RCI Scientist receives the Humboldt Research Fellowship
22.09.2021RCI scientist, Mario Lecce, PhD, has received the prestigious Humboldt Research Fellowship, which addresses and supports post-doctoral researchers with outstanding qualifications.
Category: 1
RCI joins the Federal and State Funding of the Leibniz Association to become the “Leibniz Institute for Immunotherapy”
02.07.2021Newly Announced Federal and State Funding for Regensburg Center Opens New Era of Cutting Edge Research for Prestigious Medical Institute
RCI receives the Total E-Quality Award
07.06.2021The Total E-Quality award was created in 1996 to produce and promote awareness about gender-equality in the workplace.
iOmx Therapeutics receives 65 million financing
10.05.2021iOmx Therapeutics AG (iOmx) is a biopharmaceutical company co-founded by RCI scientists, that develops cancer therapeutics based on novel immune checkpoint targets.
Human immune cells can be programmed to repair tissue damage
30.03.2021The immune system’s main function is to defend the body against infections or cancer.
Footprints on the genome – how immune cells orchestrate their functions
10.03.2021New Publication in the journal “Nature Communications”.
A good/bad turn: breast cancer hijacks developing-killer cells to acquire cancer promoting features
24.02.2021Regulatory T cells (Treg) are a type of immune cells that protect tissues from dysregulated immune attack.
PopDel, a new software to detect large DNA deletions
08.02.2021Scientists from the Regensburg Center for Interventional Immunology (RCI) and the Berlin Institute of Health (BIH) have teamed up with Icelandic researchers to develop PopDel, a software that reliably and quickly identifies large deletions in ten-thousands of genomes simultaneously.
RCI rides high towards the Leibniz Association
25.01.2021The Regensburg Center for Interventional Immunology (RCI) received today the final evaluation by the German Council of Science and Humanities, with regard to its application to join the Leibniz Association.
Robert-Koch-Award 2020 to Shimon Sakaguchi
16.11.2020Immunologist Shimon Sakaguchi, a member of the RCI Scientific Advisory Board, is honored with the Robert-Koch-Award this year.